EGFR and lung carcinoma: Additionally, combined treatment with afatinib and suberoylanilide hydroxamic acid (SAHA), a histone deacetylase (HDAC) inhibitor, evoked proapoptotic autophagy in EGFR T790M-mutated lung cancer cells [16].